Press Releases

Let's spread the word about Immunotherapy! Click to share this page with your community.
September 20, 2017

CRI and Parker Institute Announce First Patients in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy

Cancer Research Institute collaboration with the Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb, and Apexigen will test CD40 antibody APX005M, nivolumab, and chemotherapy in pancreatic cancer patients.

August 02, 2017

CRI and ICRF Partner to Fund Immunotherapy Research in Israel

First-of-its kind campaign to fund promising immunotherapy research in Israel, a global leader in cancer research

June 28, 2017

CRI and Fight CRC Announce $400k Grant to Support Colorectal Cancer Immunotherapy Research

Fight Colorectal Cancer and the Cancer Research Institute announce the recipient of their jointly-funded $400k grant to support immunotherapy research in metastatic colorectal cancer.

June 26, 2017

CRI Announces $1 Million Technology Impact Award Recipient

CRI's largest grant to a single investigator will support development of microchip-based research models of cancer and the immune system

June 22, 2017

Focused Ultrasound Foundation and CRI Partner to Advance Cancer Immunotherapy

The Focused Ultrasound Foundation (FUSF) and the Cancer Research Institute (CRI) are establishing a partnership with the goal of advancing the development of new focused ultrasound (FUS) and cancer immunotherapy treatments.

*Immunotherapy results may vary from patient to patient.